Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”
Retail cannabis distribution in Colorado is associated with a reduction in opioid-related mortality, according to data published online ahead of print in The American Journal of Public Health. Authors reported: “Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado.”
The Legion recently ramped up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis by sending him a letter demanding for his direct involvement in making sure the medical marijuana study meets its goals.
That letter was sent on September 19th. 17 days ago.
What’s a medical marijuana card-holding college student to do when they are required to live in on-campus housing but their medicine is banned from the premises?